Abstract
Introduction: Carbapenems constitute one of the groups of antibiotics used in the treatment of infections caused by multiresistant Enterobacteriaceae isolated from clinical samples. Resistance to these antibiotics is caused mainly by enzymes that hydrolyze this group of antibiotics, among which the most studied are class A carbapenemases (such as KPC), class B carbapenemases (metallo beta-lactamases such as NDM, IMP and VIM) and those of class D (oxacillinases such as OXA-48 and its variants). Objectives: The present work describes the epidemiological, phenotypic and molecular characteristics of carbapenemase-producing Enterobacteriaceae (CPE) isolated in different health centers in the city of Mar del Plata, Buenos Aires, Argentina. Results: About 45% (47/103) of the isolates were producers of KPC, 44% (45/103) of OXA-163, 8% (8/103) of NDM, and 3% were double carbapenemase-producing Enterobacteriaceae (1 KPC + NDM and 2 OXA-163 + NDM). Twenty-five of the 103 strains were isolated from surveillance swab samples, while the remaining 78 were from clinical samples of infections. Klebsiella pneumoniae was the main carbapenemase-producing agent, with KPC and OXA-163-type enzymes being the most prevalent in the city. Discussion: It is of great importance to know the epidemiology of CPE, since due to the increase in the indiscriminate use of antibiotics, antimicrobial resistance has become a threat to public health.
References
Famiglietti A, Quinteros M, Vázquez M, Marín M, Nicola F, Radice M, et al. Consenso sobre las pruebas de sensibilidad a los antimicrobianos en Enterobacteriaceae. Rev Argent Microbiol. 2005;37: 57-66.
Lazovski J, Corso A, Pasteran F, Monsalvo M, Frenkel J, Cornistein W, et al. Estrategia de control de la resistencia bacteriana a los antimicrobianos en Argentina. Rev Panam Salud Pública. 2018;41:e88.
Navarro F, Miró E, Mirelis B. Lectura interpretada del antibiograma de enterobacterias. Enfermedades Infecc Microbiol Clínica. 2010;28(9):638-45.
Gomez S, Rapoport M, Togneri A, Viegas-Caetano J, Faccone D, Corso A, et al. Emergence of Metallo-β-lactamases in Enterobacteriaceae from Argentina. Diagn Microbiol Infect Dis. 2011;69(1):94-7.
García DMM. Carbapenemasas, una amenaza actual. Rev Cuba Med Intensiva Emerg. 2012;11(4):2613-2618.
Vera-Leiva A, Barría-Loaiza C, Carrasco-Anabalón S, Lima C, Aguayo- Reyes A, Domínguez M, et al. KPC: Klebsiella pneumoniae carbapenemasa, principal carbapenemasa en enterobacterias. Rev Chil Infectol. 2017;34(5):476-84.
Córdova E, Lespada MI, Gómez N, Pasterán F, Oviedo V, Rodríguez-Ismael C. Descripción clínica y epidemiológica de un brote nosocomial por Klebsiella pneumoniae productora de KPC en Buenos Aires, Argentina. Enfermedades Infecc Microbiol Clínica. 2012;30(7):376-379.
Center of Disease Control and Prevention. Detection of Enterobacteriaceae Isolates Carrying Metallo-Beta-Lactamase - United States, 2010. Morb Mortal Wkly Rep. 2010;59(24):750.
Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New Delhi Metallo- β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis. 2011;17(1):103.
Pasteran F, Meo A, Gomez S, Derdoy L, Albronoz E, Faccone D, et al. Emergence of genetically related NDM-1-producing Providencia rettgeri strains in Argentina. J Glob Antimicrob Resist. 2014;2(4):344-345.
Carrascoso GR. Características microbiológicas y clínico-epidemiológicas de enterobacterias productoras de carbapenemasa oxa-48 en el contexto de un brote hospitalario. Tesis inédita de la Universidad Complutense de Madrid, Facultad de Farmacia, Departamento de Microbiología. 2016.
World Health Organization. Regional Office for Europe. Antimicrobial resistance: global report on surveillance. Geneva, Switzerland: World Health Organization; 2014. Disponible en: https://apps.who.int/iris/handle/10665/346076
Anchordoqui MS, De Belder D, Lucero C, Rapoport M, Faccone D, RodriguezA, et al. In vivo horizontal dissemination of the blaKPC-2 gene carried on diverse genetic platforms among clinical isolates of Enterobacteriaceae. J Glob Antimicrob Resist. 2015;3(3):210-213.
14. Gomez SA, Pasteran FG, Faccone D, Tijet N, Rapoport M, Lucero C, et al. Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina. Clin Microbiol Infect. 2011;17(10):1520-1524.
Cejas D, Elena A, Guevara Nuñez D, Sevillano Platero P, De Paulis A, Magariños F, et al. Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307. J Glob Antimicrob Resist. 2019;18:238-242.
Hara GL, Gould I, Endimiani A, Pardo PR, Daikos G, Hsueh PR, et al. Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae : Recommendations from an International Working Group. J Chemother. 2013;25(3):129-140.
Lupo A, Papp-Wallace KM, Sendi P, Bonomo RA, Endimiani A. Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms
in Enterobacteriaceae. Diagn Microbiol Infect Dis. 2013;77(3):179-194. 18. CLSI : Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility. M100-S27. 2020.
Prat Miranda MS. Recomendaciones para detección de carbapenemasas en enterobacterias y Pseudomonas aeruginosa. Chile: Instituto de Salud Pública. Ministerio de Salud; 2018.
Nastro DM, de Gregorio S, Rodríguez H, Farina J, Foccoli M, Vay C, et al. Enterobacterias portadoras de KPC en un hospital universitario. Rev Asoc Médica Argent. 2016;129(2):3.
Tártara SG. Patógenos emergentes - Tercera parte «Klebsiella pneumoniae productora de carbapenemasas (Kpn-KPC)». Rev Nefrol Dial Traspl. 2013;33(2):7.
Gritti MA, Favalesso MM, Capará LGG, Peichoto ME. Resistencia a antibióticos de relevancia clínica en un hospital de Corrientes. Medicina (Mex). 2021;81(6):8. 23. Pasteran F, Ceriana P, Lucero C, Faccone D, Gomez S, De Belder D, et al. Emergence of Enterobacterales with co-expression of two carbapenemases during COVID-19 pandemic in Argentina: KPC+NDM, NDM+OXA-48 and KPC+IMP. 2021. Disponible en: http://antimicrobianos.com.ar/ATB/wp-content/uploads/2021/04/Emergence-of-Enterobacterales-withco-expression-of-two-carbapenemases-during-COVID-19-pandemic-in-Argentina.pdf